|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of Sales | |||||
| Gross Profit | |||||
| Selling, General and Administrative Expenses | |||||
| Gain on Involuntary Conversions (Note 5) | |||||
| Operating Income (Loss) | |||||
| Other Income (Expense): | |||||
| Federal tax credits realized | |||||
| Other Income | |||||
| Interest Expense | |||||
| Income (Loss) before Income Taxes | |||||
| Benefit (Provision) for Income Taxes | |||||
| Income Attributable to Non-controlling Interest | |||||
| Net Income (Loss) | |||||
| Preferred Dividends | |||||
| Net Income (Loss) Attributable to Common Stockholders | |||||
| Net Earnings (Loss) Per Share of Common Stock - | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted Average Shares of Common Stock Outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...